Table 2 Demographic and clinical characteristics of rheumatoid arthritis paired serum and synovial fluid (enzyme-linked immunosorbent assay)
From: FMS-related tyrosine kinase 3 ligand (Flt3L)/CD135 axis in rheumatoid arthritis
|  | Rheumatoid arthritis paired samples (n = 9) |
|---|---|
Age (years) | 58 ± 14 |
Sex, female/male | 5/2 |
Disease duration (years) | 15 ± 6 |
Swollen joint count | 4 ± 4 |
C-reactive protein (mg/l) | 20 ± 25 |
Disease Activity Score in 28 joints | 4.3 ± 2.5 |
Erythrocyte sedimentation rate (mm/hour) | 31.1 ± 23.1 |
IgM-RF (kU/l) | 117.25 ± 273.1 |
Anti-CCP (kAU/ml) | 290.7 ± 447.9 |
Number taking NSAIDS (positive/negative) | 1/9 |
Number taking corticosteroids (positive/negative) | 6/9 |
Number taking DMARDs (positive/negative) | 0/9 |
Number taking anti-tumor necrosis factor (positive/negative) | 2/9 |